Sodium-ion, solar, and Wegovy maker: A look at NC’s 5 largest job announcements of 2024
Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
A Diet Writer’s Regrets
No one has ever known so much about healthy eating and been less successful at following her own advice.
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...
Rift in Trump world? Are Elon Musk and Robert F Kennedy Jr clashing over weight loss drugs?
Elon Musk, the richest man in the world and self-described ‘First Buddy’, on Wednesday signalled his support for weight loss ...
I lost two stone in three months by doing ‘Wegovy Wednesday’ – the midweek ‘Ozempic’ trend
Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
A woman who lost 100 pounds on semaglutide shared 3 ways the holiday season has changed — including not feeling the need to diet in the new year
At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...
Elon Musk upgrades to 'King Kong' of weight-loss drugs after taking Ozempic as he shares slimmed-down Santa picture at Christmas
Elon Musk, 53, admitted to taking Mounjaro, a drug that typically treats type-2 diabetes by lowering a person's blood sugar ...
Tyler Morning Telegraph20h
Medicaid Now Covers GLP-1s for Obesity in Texas
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
24/7 Wall St22h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
Will Novo Nordisk (NVO) Stock Recover To $145 Levels?
Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...